KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scotts Miracle-Gro (SMG) Share-based Compensation (2016 - 2025)

Scotts Miracle-Gro's Share-based Compensation history spans 17 years, with the latest figure at $7.4 million for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 52.26% year-over-year to $7.4 million; the TTM value through Dec 2025 reached $60.9 million, down 23.78%, while the annual FY2025 figure was $69.0 million, 14.18% down from the prior year.
  • Share-based Compensation for Q4 2025 was $7.4 million at Scotts Miracle-Gro, down from $13.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $37.4 million in Q2 2023 and bottomed at -$5.6 million in Q3 2023.
  • The 5-year median for Share-based Compensation is $15.5 million (2024), against an average of $14.3 million.
  • The largest annual shift saw Share-based Compensation tumbled 203.7% in 2023 before it skyrocketed 476.79% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $6.6 million in 2021, then surged by 216.67% to $20.9 million in 2022, then fell by 23.44% to $16.0 million in 2023, then decreased by 3.12% to $15.5 million in 2024, then plummeted by 52.26% to $7.4 million in 2025.
  • Per Business Quant, the three most recent readings for SMG's Share-based Compensation are $7.4 million (Q4 2025), $13.4 million (Q3 2025), and $17.5 million (Q2 2025).